Haoyuan Pharmaceutical
SSE · 688131
Record TypeProfile record
Record UpdatedJun 4, 2026
Market Cap$16.2B
Revenue$3.0B
Employees4195
Listed OnSSE
Ticker688131
CEO / ExecMr. Baofu Zheng
HeadquartersShanghai
MarketMainland China
Websitewww.chemexpress.cn
Overview
Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.
Source Note
This record combines exchange fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.